Health Condition 1: B029- Zoster without complications
Conditions
Interventions
Intervention1: zinc sulphate oral tablet: Study group: 24 patients with
acute herpes zoster infection will receice zinc
sulphate tablet 40mg od starting from the day of presentation along with the
Sponsors
Pt BD Sharma University of health and science PGIMS Rohtak Haryana
Eligibility
Inclusion criteria
Inclusion criteria: : Patients of age group > 18 years of either sex referred to Pain Clinic from Skin OPD after establishing the diagnosis of acute herpes zoster infection (fever, pain and maculo-papular/vesicular rash), presenting within first week of acute phase and willing to participate in the study will be included in this study.
Exclusion criteria
Exclusion criteria: 1.Patients with any other cause of fever 2.any history of severe medical illness (i.e. cardiac diseases, diabetes mellitus, liver disease, renal disease, CNS disorders) 3.Pregnant and lactating females 4. 4. Already taking any kind of zinc supplement, antiviral or analgesic other than standardized treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score, pre and post administration of oral zinc sulphate tablet in patients with acute herpes zosterTimepoint: T0: at time of presentation T1: at end of first week of acute herpes zoster T2: at end of second week of acute herpes zoster T3:at end of third week of acute herpes zoster T4: at end of fourth week of acute herpes zoster | — |
Secondary
| Measure | Time frame |
|---|---|
| note and treat side effects of oral zinc sulphate, if any Timepoint: T0: at time of presentation T1: at end of first week of acute herpes zoster T2: at end of second week of acute herpes zoster T3:at end of third week of acute herpes zoster T4: at end of fourth week of acute herpes zoster | — |
Countries
India
Contacts
Public ContactDr Cheshta Sangwan
Pt. BD Shrama PGIMS, Rohtak
Outcome results
None listed